These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Atazanavir-containing renal calculi in an HIV-infected patient. Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108 [No Abstract] [Full Text] [Related]
23. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results. Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E; Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947 [TBL] [Abstract][Full Text] [Related]
24. Urolithiasis in HIV-positive patients treated with atazanavir. Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904 [TBL] [Abstract][Full Text] [Related]
25. Case presentation: nephrolithiasis in a patient treated with atazanavir. Savini C; James C; Wilson S; Martin H; Szabo S; Scotto V J Assoc Nurses AIDS Care; 2008; 19(3):225-7. PubMed ID: 18457764 [TBL] [Abstract][Full Text] [Related]
26. Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study). Di Giambenedetto S; Fabbiani M; Colafigli M; Ciccarelli N; Farina S; Sidella L; D'Avino A; Mondi A; Cingolani A; Tamburrini E; Murri R; Navarra P; Cauda R; De Luca A J Antimicrob Chemother; 2013 Jun; 68(6):1364-72. PubMed ID: 23372058 [TBL] [Abstract][Full Text] [Related]
27. Atazanavir urinary stones in an HIV-infected patient. Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366 [No Abstract] [Full Text] [Related]
28. Woman With a Groin Mass. Hasslinger CI; Allison CF; Barker JJ; Muns EE; Mackenzie DC Ann Emerg Med; 2018 Nov; 72(5):e107-e108. PubMed ID: 30342740 [No Abstract] [Full Text] [Related]
29. Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz. Kummer O; Mossdorf E; Battegay M; Elzi L; Bodmer M; Krähenbühl S; Haschke M Gut; 2007 Oct; 56(10):1477-8. PubMed ID: 17872579 [No Abstract] [Full Text] [Related]
30. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease. Calista D; Morri M Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600 [No Abstract] [Full Text] [Related]
31. [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile]. MMW Fortschr Med; 2008 Apr; 150 Spec No 1():42-3. PubMed ID: 19024917 [No Abstract] [Full Text] [Related]
32. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. Henry K; Kitch D; Dube M; Zackin R; Parker RA; Sprecher D; Hammer S; Currier J; AIDS; 2004 Dec; 18(18):2434-7. PubMed ID: 15622323 [No Abstract] [Full Text] [Related]
33. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus. Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112 [TBL] [Abstract][Full Text] [Related]
34. Pseudoaneurysm of the superficial femoral artery associated with osteochondroma--a case report. Blazick E; Keeling WB; Armstrong P; Letson D; Back M Vasc Endovascular Surg; 2005; 39(4):355-8. PubMed ID: 16079946 [TBL] [Abstract][Full Text] [Related]